| 326030 Stock | | | 103,800 500.00 0.48% |
Sk Biopharmaceutica kurtosis technical analysis lookup allows you to check this and other technical indicators for Sk Biopharmaceuticals Co or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also
Equity Screeners to view more equity screening tools
Sk Biopharmaceuticals Co has current Kurtosis of 0.5205. Kurtosis is a measure of the return distribution. In a similar way to the concept of skewness, kurtosis is a descriptor of the shape of a return distribution. There are various interpretations of kurtosis, and of how particular measures should be interpreted; these are primarily peakedness (width of peak), tail weight, and lack of shoulders (distribution primarily peak and tails, not in between).
Sk Biopharmaceutica Kurtosis Peers Comparison
326030 Kurtosis Relative To Other Indicators
Sk Biopharmaceuticals Co is rated
fifth in kurtosis category among its peers. It is number one stock in maximum drawdown category among its peers reporting about
24.60 of Maximum Drawdown per Kurtosis. The ratio of Maximum Drawdown to Kurtosis for Sk Biopharmaceuticals Co is roughly
24.60 A high kurtosis typically shows a distribution of returns with fat tails, whereas a low kurtosis portrays a distribution with skinny tails or a distribution concentrated toward the mean.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.